The Catalan Agency for Health Technology Assessment (CAHTA) (Agència d’Avaluació de Tecnologia i Recerca Mèdiques de Catalunya - AATRM) is a Spanish public enterprise that is a pioneer for its pathbreaking service to the public government with regard to a better performance in health care and services.
This application needs to be put into context, as there were not many initiatives for an innovative public enterprise model like CAHTA in Southern Europe at the time of its creation, either with regard to its internal functional design, or for the model of governance adopted or for the type of service provided to the public administration to assist in better decision making and therefore a better performance. The way in which this application was prepared is also innovative, as it was initiated by the professional workers with the support of the management. Every cluster group went through the process of selecting the items that best represent the innovative characteristics and roles of CAHTA. This application was therefore prepared and completed by a varied group of CAHTA professionals from different sub-disciplines, roles and responsibilities. We believe there are many reasons why we deserve this prize for our long-standing effort to assist public administration in achieving a better performance, a healthier health system and a decision-making architecture in which scientific research and results are taken into consideration.
CAHTA essentially produces what is called ‘health technology assessment’ products, that is to say, evaluates health devices, drugs, sanitary processes, and organisation and rationalisation of the health system for improved efficiency, efficacy, equity, quality and performance. Furthermore, CAHTA assists public and clinical decision-makers through the identification and promotion of research holes of utility to enable informed decisions to be taken. CAHTA has therefore established an innovative system of prioritisation for research topics to detect the needs of decision-makers through the ‘call for topics’, which is followed by an equally innovative (within the Spanish context) ‘call for research’ based on three assessment processes: 1) the ex-ante assessment and selection process, 2) the ongoing assessment process and 3) assessment of the impact of research beyond the scientific world (that is to say, an assessment of the use of research for decision-making and its impact on health and well-being). Finally, CAHTA is also innovative in the communication strategies it adopts, as it considers this process just as important as the production of CAHTA products itself. That is to say that CAHTA’s strategic plan allows for a number of well-established channels of communication to make CAHTA’s products, services and messages reach their target audience and enhance its reception and usage. Furthermore, and also as a strategic plan for ensuring the best services and products, CAHTA is continuously seeking international collaboration and feed-back, as well as collaborations with other peer organisations across Europe.
|Award category:||public service delivery|
|Sector:||Public health and social welfare/affairs|
|Type of activity:|
|Keywords:||Health care services, health technology assessment, informed decision-making, evidence-based decision making, transfer, social impact of health research, rational drug usage.|
|Short English description:||CAHTA essentially produces what is called ‘health technology assessment’ products, that is to say, evaluates health devices, drugs, sanitary processes, and organisation and rationalisation of the health system for improved efficiency, efficacy, equity, quality and performance|
|Organisation:||Catalan Agency for Health Technology Assessment (CAHTA)|
|Level of government:||regional level|
|Size of organisation:||25-50|
|Number of people involved:|
|EU membership:||EU member|